These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36316692)

  • 1. Proenkephalin A 119-159 predicts early and successful liberation from renal replacement therapy in critically ill patients with acute kidney injury: a post hoc analysis of the ELAIN trial.
    von Groote T; Albert F; Meersch M; Koch R; Porschen C; Hartmann O; Bergmann D; Pickkers P; Zarbock A
    Crit Care; 2022 Oct; 26(1):333. PubMed ID: 36316692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Proenkephalin A 119-159 for liberation from renal replacement therapy: an external, multicenter pilot study in critically ill patients with acute kidney injury.
    von Groote T; Albert F; Meersch M; Koch R; Gerss J; Arlt B; Sadjadi M; Porschen C; Pickkers P; Zarbock A;
    Crit Care; 2023 Jul; 27(1):276. PubMed ID: 37430375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial.
    Zarbock A; Kellum JA; Schmidt C; Van Aken H; Wempe C; Pavenstädt H; Boanta A; Gerß J; Meersch M
    JAMA; 2016 May 24-31; 315(20):2190-9. PubMed ID: 27209269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and Outcome of Subclinical Acute Kidney Injury Using penKid in Critically Ill Patients.
    Dépret F; Hollinger A; Cariou A; Deye N; Vieillard-Baron A; Fournier MC; Jaber S; Damoisel C; Lu Q; Monnet X; Rennuit I; Darmon M; Leone M; Guidet B; Sonneville R; Montravers P; Pili-Floury S; Lefrant JY; Duranteau J; Laterre PF; Brechot N; Oueslati H; Cholley B; Struck J; Hartmann O; Mebazaa A; Gayat E; Legrand M
    Am J Respir Crit Care Med; 2020 Sep; 202(6):822-829. PubMed ID: 32516543
    [No Abstract]   [Full Text] [Related]  

  • 5. Circulating Proenkephalin, Acute Kidney Injury, and Its Improvement in Patients with Severe Sepsis or Shock.
    Caironi P; Latini R; Struck J; Hartmann O; Bergmann A; Bellato V; Ferraris S; Tognoni G; Pesenti A; Gattinoni L; Masson S;
    Clin Chem; 2018 Sep; 64(9):1361-1369. PubMed ID: 30012641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of renal replacement therapy initiation for acute kidney injury in critically ill patients: a systematic review of randomized clinical trials with meta-analysis and trial sequential analysis.
    Li X; Liu C; Mao Z; Li Q; Zhou F
    Crit Care; 2021 Jan; 25(1):15. PubMed ID: 33407756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PenKid measurement at admission is associated with outcome in severely ill burn patients.
    Dépret F; Polina A; Amzallag J; Fayolle-Pivot L; Coutrot M; Chaussard M; Struck J; Hartmann O; Jully M; Fratani A; Oueslati H; Cupaciu A; Soussi S; Benyamina M; Guillemet L; Mebazaa A; Textoris J; Legrand M;
    Burns; 2020 Sep; 46(6):1302-1309. PubMed ID: 31987659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Proenkephalin A 119-159 (penKid) in Extracorporeal Therapies: Ex vivo Sieving Coefficient, Diffusive Clearance, and Hemoadsorption Kinetics.
    Lorenzin A; de Cal M; Perin N; Morisi N; Brendolan A; Lentini P; Zanella M; Ronco C
    Blood Purif; 2024; 53(10):773-780. PubMed ID: 39068927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury (The ELAIN-Trial): study protocol for a randomized controlled trial.
    Zarbock A; Gerß J; Van Aken H; Boanta A; Kellum JA; Meersch M
    Trials; 2016 Mar; 17(1):148. PubMed ID: 26993261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hierarchical endpoints in critical care: A post-hoc exploratory analysis of the standard versus accelerated initiation of renal-replacement therapy in acute kidney injury and the intensity of continuous renal-replacement therapy in critically ill patients trials.
    Zampieri FG; Serpa-Neto A; Wald R; Bellomo R; Bagshaw SM;
    J Crit Care; 2024 Aug; 82():154767. PubMed ID: 38461657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The timing of renal replacement therapy on mortality in patients with acute renal injury: a reanalysis of two recently published randomized control trials].
    Han JW; Liu JT; Ma PL
    Zhonghua Nei Ke Za Zhi; 2018 May; 57(5):355-357. PubMed ID: 29747292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors for severe long-term chronic kidney disease after acute kidney injury requiring renal replacement therapy in critically ill patients: an ancillary study of the ELVIS randomized controlled trial.
    Soum E; Timsit JF; Ruckly S; Gruson D; Canet E; Klouche K; Argaud L; Garrouste-Orgeas M; Mariat C; Vincent F; Cayot S; Darmon M; Bohé J; Schwebel C; Bouadma L; Dupuis C; Souweine B; Lautrette A
    Crit Care; 2022 Nov; 26(1):367. PubMed ID: 36447221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Approach to Successful Liberation from Renal Replacement Therapy in Critically Ill Patients with Severe Acute Kidney Injury: The Quest for Biomarkers Continues.
    Schiffl H; Lang SM
    Mol Diagn Ther; 2021 Jan; 25(1):1-8. PubMed ID: 33099671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Proenkephalin A 119-159 in the detection of acute kidney injury after open thoracoabdominal aortic repair.
    Doukas P; Hartmann O; Arlt B; Jacobs MJ; Greiner A; Frese JP; Gombert A
    Vasa; 2024 Jan; 53(1):61-67. PubMed ID: 37965700
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-Term Clinical Outcomes after Early Initiation of RRT in Critically Ill Patients with AKI.
    Meersch M; Küllmar M; Schmidt C; Gerss J; Weinhage T; Margraf A; Ermert T; Kellum JA; Zarbock A
    J Am Soc Nephrol; 2018 Mar; 29(3):1011-1019. PubMed ID: 29196304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluid balance and renal replacement therapy initiation strategy: a secondary analysis of the STARRT-AKI trial.
    Wald R; Kirkham B; daCosta BR; Ghamarian E; Adhikari NKJ; Beaubien-Souligny W; Bellomo R; Gallagher MP; Goldstein S; Hoste EAJ; Liu KD; Neyra JA; Ostermann M; Palevsky PM; Schneider A; Vaara ST; Bagshaw SM
    Crit Care; 2022 Nov; 26(1):360. PubMed ID: 36424662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated versus standard initiation of renal replacement therapy for critically ill patients with acute kidney injury: a systematic review and meta-analysis of RCT studies.
    Pan HC; Chen YY; Tsai IJ; Shiao CC; Huang TM; Chan CK; Liao HW; Lai TS; Chueh Y; Wu VC; Chen YM
    Crit Care; 2021 Jan; 25(1):5. PubMed ID: 33402204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early initiation of renal replacement therapy in critically ill patients: a meta-analysis of randomized clinical trials.
    Pasin L; Boraso S; Tiberio I
    BMC Anesthesiol; 2019 May; 19(1):62. PubMed ID: 31039744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proenkephalin A 119-159 (Penkid) Is an Early Biomarker of Septic Acute Kidney Injury: The Kidney in Sepsis and Septic Shock (Kid-SSS) Study.
    Hollinger A; Wittebole X; François B; Pickkers P; Antonelli M; Gayat E; Chousterman BG; Lascarrou JB; Dugernier T; Di Somma S; Struck J; Bergmann A; Beishuizen A; Constantin JM; Damoisel C; Deye N; Gaudry S; Huberlant V; Marx G; Mercier E; Oueslati H; Hartmann O; Sonneville R; Laterre PF; Mebazaa A; Legrand M
    Kidney Int Rep; 2018 Nov; 3(6):1424-1433. PubMed ID: 30450469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proenkephalin A and bioactive adrenomedullin are useful for risk prognostication in cardiac surgery.
    Hill A; Bergmann D; Schulte J; Zayat R; Marx G; Simon TP; Mossanen J; Brücken A; Stoppe C
    Front Cardiovasc Med; 2022; 9():1017867. PubMed ID: 36756642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.